Follow
Klaus Osterrieder
Klaus Osterrieder
Verified email at fu-berlin.de
Title
Cited by
Cited by
Year
Two-step Red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli
B Karstentischer, J von Einem, B Kaufer, N Osterrieder
Biotechniques 40 (2), 191-197, 2006
8892006
En Passant Mutagenesis: A Two Step Markerless Red Recombination System
BK Tischer, GA Smith, N Osterrieder
In Vitro Mutagenesis Protocols: Third Edition, 421-430, 2010
6342010
Marek's disease virus: from miasma to model
N Osterrieder, JP Kamil, D Schumacher, BK Tischer, S Trapp
Nature Reviews Microbiology 4 (4), 283-294, 2006
4912006
Egress of alphaherpesviruses: comparative ultrastructural study
H Granzow, BG Klupp, W Fuchs, J Veits, N Osterrieder, TC Mettenleiter
Journal of virology 75 (8), 3675-3684, 2001
4222001
Equine herpesvirus‐1 consensus statement
DP Lunn, N Davis‐Poynter, M Flaminio, DW Horohov, K Osterrieder, ...
Journal of Veterinary Internal Medicine 23 (3), 450-461, 2009
3712009
A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model
J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ...
Cell 183 (4), 1058-1069. e19, 2020
3212020
Delivery of foreign antigens by engineered outer membrane vesicle vaccines
DJ Chen, N Osterrieder, SM Metzger, E Buckles, AM Doody, MP DeLisa, ...
Proceedings of the National Academy of Sciences 107 (7), 3099-3104, 2010
3212010
The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary enveloped but not mature …
W Fuchs, BG Klupp, H Granzow, N Osterrieder, TC Mettenleiter
Journal of virology 76 (1), 364-378, 2002
3162002
Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant
D Schumacher, BK Tischer, W Fuchs, N Osterrieder
Journal of virology 74 (23), 11088-11098, 2000
2792000
Evidence for novel hepaciviruses in rodents
JF Drexler, VM Corman, MA Müller, AN Lukashev, A Gmyl, B Coutard, ...
PLoS pathogens 9 (6), e1003438, 2013
2492013
A point mutation in a herpesvirus polymerase determines neuropathogenicity
LB Goodman, A Loregian, GA Perkins, J Nugent, EL Buckles, B Mercorelli, ...
PLoS pathogens 3 (11), e160, 2007
2482007
Virus-induced senescence is a driver and therapeutic target in COVID-19
S Lee, Y Yu, J Trimpert, F Benthani, M Mairhofer, P Richter-Pechanska, ...
Nature 599 (7884), 283-289, 2021
2262021
Age-dependent progression of SARS-CoV-2 infection in Syrian hamsters
N Osterrieder, LD Bertzbach, K Dietert, A Abdelgawad, D Vladimirova, ...
Viruses 12 (7), 779, 2020
2252020
Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity
JJ Chiang, KMJ Sparrer, M van Gent, C Lässig, T Huang, N Osterrieder, ...
Nature immunology 19 (1), 53-62, 2018
2072018
SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals
NC Gassen, J Papies, T Bajaj, J Emanuel, F Dethloff, RL Chua, J Trimpert, ...
Nature communications 12 (1), 3818, 2021
1932021
The Protein Encoded by the US3 Orthologue of Marek's Disease Virus Is Required for Efficient De-Envelopment of Perinuclear Virions and Involved in Actin Stress …
D Schumacher, BK Tischer, S Trapp, N Osterrieder
Journal of virology 79 (7), 3987-3997, 2005
1582005
A virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis
S Trapp, MS Parcells, JP Kamil, D Schumacher, BK Tischer, PM Kumar, ...
The Journal of experimental medicine 203 (5), 1307-1317, 2006
1572006
Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth
F Dorange, BK Tischer, JF Vautherot, N Osterrieder
Journal of virology 76 (4), 1959-1970, 2002
1572002
Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes
L Petherbridge, AC Brown, SJ Baigent, K Howes, MA Sacco, ...
Journal of virology 78 (23), 13376-13380, 2004
1542004
Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1)
LB Goodman, B Wagner, M Flaminio, KH Sussman, SM Metzger, ...
Vaccine 24 (17), 3636-3645, 2006
1512006
The system can't perform the operation now. Try again later.
Articles 1–20